Cortexyme, Inc. (CRTX) Covered Calls

Cortexyme, Inc. covered calls Cornerstone Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products mainly for the respiratory and related markets.

You can sell covered calls on Cortexyme, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CRTX (prices last updated Fri 4:16 PM ET):

Cortexyme, Inc. (CRTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.03 -0.19 11.90 12.00 516K - 0.4
Covered Calls For Cortexyme, Inc. (CRTX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 17 12.5 0.90 11.10 8.1% 134%
Jan 21 12.5 1.65 10.35 15.9% 102%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Critical Therapeutics, Inc.. The Group's principal activities are discovering, developing and commercializing products designed to treat asthma and critical care diseases linked to body's inflammatory response. The Group currently has one FDA-approved product, Zyflo, a tablet formulation for asthma. It licensed from Abbott Laboratories the worldwide rights to ZYFLO and other formulations of zileuton for multiple diseases and conditions. The Group is in the process of changing manufacturing sites for ZYFLO. It is also developing product candidates to regulate the excessive inflammatory response that can damage vital internal organs and, in the most severe cases, result in multiple organ failure and death.